...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
【24h】

Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.

机译:根据日本胃癌分类,II期胃癌的临床病理特征和预后指标。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The characteristics of stage II gastric cancer according to the Japanese Classification of Gastric Cancer (JCGC) were examined and the high-risk factors predicting poor prognosis were detected. PATIENTS AND METHODS: In total, 107 patients, who underwent clinically curative gastrectomy with D2 lymphadenectomy for stage II gastric cancer, were included. Survival curves of the depth of invasion, lymph node metastasis, the ratio of involved: resected lymph nodes and chemotherapy treatment were compared. RESULTS: The survival curves were related to tumor invasion depth and lymph node metastasis. The ratio of involved resected lymph nodes was a good prognostic indicator compared to the classification of regional lymph node metastasis (N classification). Survival rates with adjuvant chemotherapy were slightly higher than without adjuvant chemotherapy, but the difference was not significant. CONCLUSION: pT2pN1 (stage II) gastric cancers according to the JCGC, especially pSSpN1 cases, included stageIIIB and IV gastric cancers according to the International Union Against Cancer / American Joint Committee on Cancer (UICC/AJCC); therefore, the prognosis of these might be poor. With pSSpN1 cases, according to the JCGC, anticancer chemotherapy equivalent to that required for stage III gastric cancer cases is necessary.
机译:背景:根据日本胃癌分类法(JCGC)检查了II期胃癌的特征,并发现了预后不良的高风险因素。患者与方法:总共包括107例行II期胃癌的D2淋巴结清扫术的临床治愈性胃切除术的患者。比较了浸润深度,淋巴结转移,累及比例:切除的淋巴结和化学疗法的生存曲线。结果:生存曲线与肿瘤浸润深度和淋巴结转移有关。与区域淋巴结转移的分类(N分类)相比,切除的淋巴结的比例是一个很好的预后指标。辅助化疗的生存率略高于无辅助化疗的生存率,但差异无统计学意义。结论:根据国际联合抗癌联盟/美国癌症联合委员会(UICC / AJCC),JCGC的pT2pN1(II期)胃癌,特别是pSSpN1病例,包括IIIB和IV期胃癌。因此,这些预后可能不佳。根据JCGC的研究,对于pSSpN1病例,必须进行与III期胃癌病例相同的抗癌化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号